Roberta Ballard

Advancing the state of knowledge in neonatal medicine, Dr. Roberta Ballard is a distinguished Professor Emeritus of Pediatrics at the University of California, San Francisco. With a career dedicated to the health of newborns, Dr. Ballard has carved a niche in the study and treatment of diseases affecting premature infants. Her research primarily focuses on chronic lung disease, a significant concern in neonatal care, and she has been instrumental in developing strategies to prevent and manage these conditions. Dr. Ballard's current work includes leading the groundbreaking TOLSURF trial, a multi-center study aimed at pioneering new treatments for bronchopulmonary dysplasia (BPD) in extremely low birth weight infants. This collaborative effort, alongside Dr. Dennis Black, underscores her commitment to translating research into practical solutions that enhance the quality of life for vulnerable newborns. Her leadership in this trial reflects her broader dedication to advancing neonatal care through evidence-based practices. Throughout her career, Dr. Ballard has been recognized for her contributions to pediatrics, not only in research but also in mentoring the next generation of clinicians and researchers. Her extensive body of work has been published in numerous peer-reviewed journals, highlighting her role as a thought leader in the field. Her efforts have significantly influenced the approaches to neonatal care, particularly in the management of chronic lung disease. Dr. Ballard's passion for improving health outcomes for newborns is evident in her relentless pursuit of knowledge and innovation. Her work continues to inspire and guide those in the field of pediatrics, ensuring that the youngest and most vulnerable patients receive the best possible care. Her legacy is one of dedication, innovation, and a profound impact on the lives of countless infants and their families.